ESMO GU Cancers Asia 2027 Brings Global Collaboration to GU Cancer Research
ESMO GU Cancers Asia 2027 Brings Global Collaboration to GU Cancer Research Oncodaily
Онкология
🎗️Лента новостей
Онкология
Alliance Foundation Trials and Natera Announce AFT-70 NAVIGATE: a Global, Randomized, Phase III Trial Evaluating Genentech’s Oral Selective Estrogen Receptor Degrader (SERD) with Signatera™ MRD-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Alliance Foundation Trials and Natera Announce AFT-70 NAVIGATE: a Global, Randomized, Phase III Trial Evaluating Genentech’s Oral Selective Estrogen Receptor Degrader (SERD) with Signatera™ MRD-Guided CDK4/6 Inhibitor Therapy in Breast Cancer BioSpace
Онкология
Cancer research needs greater collaboration, funding: KU VC
Cancer research needs greater collaboration, funding: KU VC KNS News
Онкология
Rasha Aboelhassan: What Truly Makes a Cancer Centre Successful?
Rasha Aboelhassan: What Truly Makes a Cancer Centre Successful? Oncodaily
Онкология
Рак молочной железы занял 19% в структуре онкозаболеваемости в России
Рак молочной железы занял 19% в структуре онкозаболеваемости в России Medvestnik
Онкология
Oncologist views on pharmacogenomic testing and implementation
More than 90% of oncologists who prescribe chemotherapy drugs such as fluoropyrimidines, thiopurines and irinotecan know genetic variants are linked to adverse events, and more than half perform pharmacogenomic testing before prescribing. “This is really encouraging,” Stuart A. Scott, PhD, professor of pathology and…
Онкология
Израильские ученые обнаружили микробелки, которые позволят отслеживать и лечить рак
Израильские ученые обнаружили микробелки, которые позволят отслеживать и лечить рак Ukr.net
🎗️
Онкология
Рак молочной железы составил 1/5 от всех онкозаболеваний в России
Рак молочной железы составил 1/5 от всех онкозаболеваний в России Readovka.news
Онкология
Израильские ученые обнаружили микробелки, которые позволят отслеживать и лечить рак - NEWSru.co.il
Израильские ученые обнаружили микробелки, которые позволят отслеживать и лечить рак - NEWSru.co.il NEWSru.co.il
🎗️
Онкология
Insurance Coverage Lags as Cancer Science, Treatment Move Forward
Insurance Coverage Lags as Cancer Science, Treatment Move Forward The Good Men Project
🎗️
Онкология
Substantial Gains In Battle Against Cancer, But Research Disruptions Pose Risks
Substantial Gains In Battle Against Cancer, But Research Disruptions Pose Risks forbes.com
Онкология
Новый анализ мочи повышает точность диагностики рака мочевого пузыря
Новый анализ мочи повышает точность диагностики рака мочевого пузыря hightech.plus
Онкология
Several patients in an ovarian cancer trial survived over a year after immune-cell treatment; one exceeded two years.
Several patients in an ovarian cancer trial survived over a year after immune-cell treatment; one exceeded two years. Stock Titan
Онкология
Anixa Biosciences Announces First Case of Stable Disease for Three Months in Ovarian Cancer CAR-T Clinical Trial
Anixa Biosciences Announces First Case of Stable Disease for Three Months in Ovarian Cancer CAR-T Clinical Trial Morningstar
Онкология
Anixa Biosciences Announces First Case of Stable Disease for Three Months in Ovarian Cancer CAR-T Clinical Trial
Anixa Biosciences Announces First Case of Stable Disease for Three Months in Ovarian Cancer CAR-T Clinical Trial PR Newswire